Government Partnerships

As a preferred large-scale fill/finish partner for the US government (USG), we have a strong history of government programs and relationships. We actively respond to solicitations and foster collaborations with innovators, drug substance CMOs, and other value chain stakeholders.   

We have partnered with organizations including the DoD, CDC, BARDA, and the Strategic National Stockpile (SNS) to address critical health threats, including COVID-19, H7N9 Influenza, botulinum toxin, and plague. We have also worked with Canada’s Strategic Innovation Fund (SIF) to increase access to medications in Canada. 

Known for our manufacturing excellence, flexibility, and responsiveness to unique customer needs, we are also highly experienced in crafting and submitting winning proposals for USG initiatives. Working with government agencies to produce therapeutics quickly under emergency situations demonstrates our abilities to handle expedited timelines. 

JHS is committed to supporting fellow BioMap, RRPV and MCDC members as part of USG programs by offering unparalleled capabilities and by fostering collaboration to enhance national preparedness and response efforts. Together, we can safeguard global health and strengthen our collective resilience.